Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Immupharma Share News (IMM)
IMM Share
Price
IMM Share
News
IMM Share
Chat
IMM Share
Trades86
IMM
Live RNS
IMM Share
Charts
IMM Level 2
Console
IMM Live
Share Price
IMM Broker
Ratings
IMM Directors
Deals
IMM Financial
Diary
IMM
Fundamentals
IMM Short
Positions
IMM
Media
IMM Company
Research
IMM Company
Timeline
Immupharma Information
Share Price Information for Immupharma (IMM)
Share Price is delayed by 15 minutes
Get Live Data
4.40
-0.41 (-8.52%)
Bid:
4.40
Ask:
4.50
Spread:
0.10 (2.273%)
Market Cap:
£27.45m
Last checked at -
Last checked at 
Intraday Immupharma Share Chart
Immupharma News
18 Nov 2021
ImmuPharma reports 'significant' progress since restructure
(Sharecast News) - Specialist drug discovery and development company ImmuPharma reported "significant" positive progress on Thursday, following major ...
1 Oct 2021
IN BRIEF: Immupharma leaves Euronext Growth Brussels market
IN BRIEF: Immupharma leaves Euronext Growth Brussels market
29 Sep 2021
IN BRIEF: ImmuPharma to make cost savings as it simplifies structure
IN BRIEF: ImmuPharma to make cost savings as it simplifies structure
29 Sep 2021
EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens
EARNINGS UPDATES: Pittards swings to profit; Immupharma loss widens
24 Aug 2021
DIRECTOR DEALINGS: Gamesys, Capital and ActiveOps execs sell shares
DIRECTOR DEALINGS: Gamesys, Capital and ActiveOps execs sell shares
12 Aug 2021
IN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial study
IN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial study
12 Aug 2021
FDA gives ImmuPharma go-ahead for pharmacokinetic study
(Sharecast News) - Specialist drug discovery and development company ImmuPharma said on Thursday that the United States Food and Drug Administration (...
30 Jul 2021
EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs
EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs
Follow the stocks
